207 related articles for article (PubMed ID: 29186361)
21. Survivin Modulates Squamous Cell Carcinoma-Derived Stem-Like Cell Proliferation, Viability and Tumor Formation in Vivo.
Lotti R; Palazzo E; Petrachi T; Dallaglio K; Saltari A; Truzzi F; Quadri M; Puviani M; Maiorana A; Marconi A; Pincelli C
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26771605
[TBL] [Abstract][Full Text] [Related]
22. Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin.
Guo H; Miao H; Gerber L; Singh J; Denning MF; Gilliam AC; Wang B
Cancer Res; 2006 Jul; 66(14):7050-8. PubMed ID: 16849550
[TBL] [Abstract][Full Text] [Related]
23. SOCS3 inhibits the pathological effects of IL-22 in non-melanoma skin tumor-derived keratinocytes.
Madonna S; Scarponi C; Morelli M; Sestito R; Scognamiglio PL; Marasco D; Albanesi C
Oncotarget; 2017 Apr; 8(15):24652-24667. PubMed ID: 28445952
[TBL] [Abstract][Full Text] [Related]
24. Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis.
Darido C; Georgy SR; Wilanowski T; Dworkin S; Auden A; Zhao Q; Rank G; Srivastava S; Finlay MJ; Papenfuss AT; Pandolfi PP; Pearson RB; Jane SM
Cancer Cell; 2011 Nov; 20(5):635-48. PubMed ID: 22094257
[TBL] [Abstract][Full Text] [Related]
25. Opposing roles for calcineurin and ATF3 in squamous skin cancer.
Wu X; Nguyen BC; Dziunycz P; Chang S; Brooks Y; Lefort K; Hofbauer GF; Dotto GP
Nature; 2010 May; 465(7296):368-72. PubMed ID: 20485437
[TBL] [Abstract][Full Text] [Related]
26. Mouse models of nonmelanoma skin cancer.
Amberg N; Holcmann M; Glitzner E; Novoszel P; Stulnig G; Sibilia M
Methods Mol Biol; 2015; 1267():217-50. PubMed ID: 25636471
[TBL] [Abstract][Full Text] [Related]
27. C/EBPβ deletion in oncogenic Ras skin tumors is a synthetic lethal event.
Messenger ZJ; Hall JR; Jima DD; House JS; Tam HW; Tokarz DA; Smart RC
Cell Death Dis; 2018 Oct; 9(11):1054. PubMed ID: 30323292
[TBL] [Abstract][Full Text] [Related]
28. Genetic susceptibility to tumor progression in mouse skin carcinogenesis.
Stern MC; Conti CJ
Prog Clin Biol Res; 1996; 395():47-55. PubMed ID: 8895983
[No Abstract] [Full Text] [Related]
29. Mice lacking MSK1 and MSK2 show reduced skin tumor development in a two-stage chemical carcinogenesis model.
Chang S; Iversen L; Kragballe K; Arthur JS; Johansen C
Cancer Invest; 2011 Mar; 29(3):240-5. PubMed ID: 21314333
[TBL] [Abstract][Full Text] [Related]
30. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis.
Chan KS; Sano S; Kataoka K; Abel E; Carbajal S; Beltran L; Clifford J; Peavey M; Shen J; Digiovanni J
Oncogene; 2008 Feb; 27(8):1087-94. PubMed ID: 17700521
[TBL] [Abstract][Full Text] [Related]
31. Conditional disruption of rictor demonstrates a direct requirement for mTORC2 in skin tumor development and continued growth of established tumors.
Carr TD; Feehan RP; Hall MN; Rüegg MA; Shantz LM
Carcinogenesis; 2015 Apr; 36(4):487-97. PubMed ID: 25740823
[TBL] [Abstract][Full Text] [Related]
32. Integrin α3β1 Is a Key Regulator of Several Protumorigenic Pathways during Skin Carcinogenesis.
Ramovs V; Krotenberg Garcia A; Kreft M; Sonnenberg A
J Invest Dermatol; 2021 Apr; 141(4):732-741.e6. PubMed ID: 32805217
[TBL] [Abstract][Full Text] [Related]
33. Genetic deletion of TNFα inhibits ultraviolet radiation-induced development of cutaneous squamous cell carcinomas in PKCε transgenic mice via inhibition of cell survival signals.
Singh A; Singh A; Bauer SJ; Wheeler DL; Havighurst TC; Kim K; Verma AK
Carcinogenesis; 2016 Jan; 37(1):72-80. PubMed ID: 26586792
[TBL] [Abstract][Full Text] [Related]
34. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.
Bowden GT; Schneider B; Domann R; Kulesz-Martin M
Cancer Res; 1994 Apr; 54(7 Suppl):1882s-1885s. PubMed ID: 8137304
[TBL] [Abstract][Full Text] [Related]
35. CENP-R acts bilaterally as a tumor suppressor and as an oncogene in the two-stage skin carcinogenesis model.
Okumura K; Kagawa N; Saito M; Yoshizawa Y; Munakata H; Isogai E; Fukagawa T; Wakabayashi Y
Cancer Sci; 2017 Nov; 108(11):2142-2148. PubMed ID: 28795467
[TBL] [Abstract][Full Text] [Related]
36. [p53 gene mutations in mouse skin tumors induced by DMBA-TPA-MNNG].
Zhang S; Guo ; Klein-Szanto A
Zhonghua Bing Li Xue Za Zhi; 1998 Aug; 27(4):298-300. PubMed ID: 11245002
[TBL] [Abstract][Full Text] [Related]
37. Suppression of skin tumorigenesis in CD109-deficient mice.
Sunagawa M; Mii S; Enomoto A; Kato T; Murakumo Y; Shiraki Y; Asai N; Asai M; Nagino M; Takahashi M
Oncotarget; 2016 Dec; 7(50):82836-82850. PubMed ID: 27756876
[TBL] [Abstract][Full Text] [Related]
38. Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma.
DeYoung MP; Johannessen CM; Leong CO; Faquin W; Rocco JW; Ellisen LW
Cancer Res; 2006 Oct; 66(19):9362-8. PubMed ID: 17018588
[TBL] [Abstract][Full Text] [Related]
39. Loss of Grainy head-like 1 is associated with disruption of the epidermal barrier and squamous cell carcinoma of the skin.
Mlacki M; Darido C; Jane SM; Wilanowski T
PLoS One; 2014; 9(2):e89247. PubMed ID: 24586629
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of chemical cooperative carcinogenesis by epidermal Langerhans cells.
Lewis JM; Bürgler CD; Fraser JA; Liao H; Golubets K; Kucher CL; Zhao PY; Filler RB; Tigelaar RE; Girardi M
J Invest Dermatol; 2015 May; 135(5):1405-1414. PubMed ID: 25233073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
